000 01890 a2200469 4500
005 20250516183701.0
264 0 _c20140317
008 201403s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2013.49.8386
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPark, Kyung
245 0 0 _aTMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJan 2014
300 _a206-11 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBiopsy
650 0 4 _aDisease Progression
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGene Fusion
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aOncogene Proteins, Fusion
_xgenetics
650 0 4 _aProstatic Intraepithelial Neoplasia
_xdiagnosis
650 0 4 _aProstatic Neoplasms
_xdiagnosis
650 0 4 _aToremifene
_xtherapeutic use
650 0 4 _aUp-Regulation
700 1 _aDalton, James T
700 1 _aNarayanan, Ramesh
700 1 _aBarbieri, Christopher E
700 1 _aHancock, Michael L
700 1 _aBostwick, David G
700 1 _aSteiner, Mitchell S
700 1 _aRubin, Mark A
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 32
_gno. 3
_gp. 206-11
856 4 0 _uhttps://doi.org/10.1200/JCO.2013.49.8386
_zAvailable from publisher's website
999 _c23328999
_d23328999